GO:0004842 ubiquitin-protein transferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004842 (ubiquitin-protein transferase activity) describes the catalytic transfer of ubiquitin from a ubiquitin-conjugated donor (X-Ub) to an acceptor protein (Y), forming a covalent Y-Ub linkage.
• This activity is executed by a hierarchical enzymatic cascade: an E1 activating enzyme, an E2 conjugating enzyme, and an E3 ligase that determines substrate specificity.
• The Parkinson's disease proteins PINK1 and Parkin are a paradigm for the pathway: PINK1 phosphorylates ubiquitin to activate Parkin E3 ligase activity, and Parkin activation can also be achieved by molecular glue compounds.
• Loss of PINK1/Parkin-mediated ubiquitin transfer causes mitochondrial dysfunction and STING-driven inflammation, linking GO:0004842 to neurodegeneration and innate immunity.
• Mitophagy, the selective autophagic clearance of damaged mitochondria, depends on ubiquitin transfer and is regulated by the AMPK/ULK1 axis and RAB7.
• Dysregulated ubiquitin transfer contributes to oxidative stress, autophagy imbalance, and NLRP3 inflammasome activation in disease models.
Description
Ubiquitin-protein transferase activity (GO:0004842) is a molecular function that catalyzes the covalent attachment of ubiquitin to a target protein, following the general reaction X-Ub + Y = Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. This post-translational modification is central to nearly every cellular process, from protein quality control and signal transduction to mitochondrial homeostasis and immune defense. Researchers study GO:0004842 because its dysregulation is implicated in neurodegeneration, inflammation, and metabolic disease, and because the enzymes that carry it out are tractable drug targets. The pathway is best understood through the PINK1/Parkin axis, where PINK1 phosphorylates ubiquitin to activate Parkin E3 ligase activity during mitophagy. Parkin activation can also be triggered by small-molecule molecular glues, demonstrating that the transferase activity is chemically tunable. Beyond mitophagy, ubiquitin transfer intersects with oxidative stress, autophagy, and inflammasome signaling, making it a hub for cellular stress responses.
ubiquitin-protein transferase activity At A Glance
| GO ID | GO:0004842 |
|---|---|
| GO term | ubiquitin-protein transferase activity |
| Ontology | molecular_function |
| Definition | Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y = Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. |
| Synonyms | E2, E3, ubiquitin conjugating enzyme activity, ubiquitin-conjugating enzyme activity, ubiquitin ligase activity, ubiquitin protein ligase activity, ubiquitin protein-ligase activity |
| Major function | Covalent attachment of ubiquitin to substrate proteins, a key post-translational modification |
| Representative enzymes | E1 activating enzymes, E2 conjugating enzymes, E3 ligases such as Parkin (PRKN) |
| Key regulator | PINK1-mediated phosphorylation of ubiquitin and Parkin |
| Disease relevance | Neurodegeneration, inflammation, mitophagy disorders |
What Is GO:0004842?
GO:0004842, ubiquitin-protein transferase activity, is defined as the catalysis of ubiquitin transfer from one protein to another via the reaction X-Ub + Y = Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. In practice, this means an enzyme (often called an E3 ligase or, historically, a ubiquitin-conjugating enzyme) uses a thioester-linked ubiquitin donor to form an isopeptide bond between the C-terminal glycine of ubiquitin and a lysine residue on the substrate. The term encompasses E2 ubiquitin-conjugating enzyme activity and E3 ubiquitin ligase activity, reflecting the multi-enzyme nature of the reaction.
Why Is ubiquitin-protein transferase activity Important in Cell Biology?
Ubiquitin-protein transferase activity is essential for proteostasis, signal transduction, and organelle quality control. It governs the degradation, localization, and activity of thousands of proteins, and its dysfunction is linked to Parkinson's disease, cancer, and inflammatory disorders. The PINK1/Parkin pathway exemplifies how ubiquitin transfer maintains mitochondrial health, and its failure triggers STING-mediated inflammation. Because the activity is enzymatically tractable, it is a major focus for drug discovery, including molecular glues that activate Parkin.
• Controls protein degradation and turnover via the ubiquitin-proteasome system.
• Regulates mitophagy and mitochondrial quality control through PINK1/Parkin.
• Suppresses STING-induced inflammation by clearing damaged mitochondria.
• Modulates oxidative stress and autophagy crosstalk.
• Influences NLRP3 inflammasome activation via metabolic signaling.
• Required for oocyte meiosis and quality control during ovarian aging.
• Provides a druggable target for neurodegenerative disease.
• Central to immune sensing and viral restriction pathways.
• Coordinates with AMPK/ULK1 energy-sensing axes.
• Offers biomarkers and therapeutic entry points in cancer and inflammation.
Molecular Mechanism of ubiquitin-protein transferase activity
Ubiquitin Activation by E1
In simple terms: The first step is like charging a battery: ubiquitin is activated by an E1 enzyme using ATP.
In an ATP-dependent reaction, the E1 activating enzyme forms a thioester bond between its catalytic cysteine and the C-terminal glycine of ubiquitin. This activated ubiquitin is then transferred to an E2 conjugating enzyme. This step is a prerequisite for all downstream ubiquitin transfer reactions, including those mediated by Parkin.
E2 Conjugation and E3 Ligase Recruitment
In simple terms: The charged ubiquitin is handed to a carrier (E2), which teams up with a targeting factor (E3) to find the right substrate.
The E2 enzyme receives ubiquitin from E1 and interacts with an E3 ligase. The E3 ligase provides substrate specificity by binding target proteins. In the PINK1/Parkin pathway, Parkin is the E3 ligase, and its activation requires PINK1-mediated phosphorylation of ubiquitin. Molecular glues can also promote Parkin activation by stabilizing its active conformation.
Substrate Recognition and Ubiquitin Transfer
In simple terms: The E3 ligase acts like a matchmaker, bringing the ubiquitin-loaded E2 close to the target protein so ubiquitin can be attached.
The E3 ligase binds a specific substrate and positions it near the E2-ubiquitin thioester. The ubiquitin is then transferred to a lysine residue on the substrate, forming an isopeptide bond. This reaction is the defining catalytic event of GO:0004842. For Parkin, substrate recognition is coupled to mitochondrial damage and PINK1 activation.
Polyubiquitin Chain Formation and Signaling
In simple terms: Multiple ubiquitin molecules can be linked together into chains, which act as different signals for the cell.
After the first ubiquitin is attached, additional ubiquitin molecules can be conjugated to form polyubiquitin chains. The linkage type (e.g., K48, K63) determines the fate of the substrate, such as proteasomal degradation or signaling. In mitophagy, ubiquitin chains on mitochondrial proteins recruit autophagy receptors.
Regulation by Phosphorylation and Energy Sensors
In simple terms: The activity is switched on and off by other enzymes and by the cell's energy status.
PINK1 phosphorylates ubiquitin and Parkin to activate the E3 ligase. The AMPK/ULK1 axis integrates energy stress with mitophagy, influencing ubiquitin-dependent clearance. RAB7 activity is also required for mitophagy regulation in oocytes.
Key Genes Involved in GO:0004842 ubiquitin-protein transferase activity
The following genes encode core components and regulators of ubiquitin-protein transferase activity, with emphasis on the PINK1/Parkin axis and associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PINK1 | Serine/threonine kinase that phosphorylates ubiquitin and Parkin to activate E3 ligase activity | Central to mitophagy and Parkinson's disease models |
| PRKN (Parkin) | E3 ubiquitin ligase that transfers ubiquitin to mitochondrial substrates | Mutations cause early-onset Parkinson's disease; target for molecular glues |
| ULK1 | Autophagy-initiating kinase regulated by AMPK | Links energy sensing to mitophagy |
| AMPK | Energy sensor that activates ULK1 and mitophagy | Modulates ubiquitin-dependent clearance |
| RAB7 | Small GTPase required for autophagosome-lysosome fusion | Regulates mitophagy in oocyte meiosis |
| STING1 | Innate immune adaptor activated by cytosolic DNA | Suppressed by PINK1/Parkin-mediated mitophagy |
| NLRP3 | Inflammasome sensor | Activated by metabolic signals linked to ubiquitin stress |
| ALDOA | Glycolytic enzyme that maintains NLRP3 activation via AMPK | Connects metabolism to inflammasome |
| cGAS | Cytosolic DNA sensor | Activated by viral proteins and centromeric DNA amplification |
| SQSTM1 (p62) | Autophagy receptor that binds ubiquitin chains | Mediates selective autophagy of ubiquitinated cargo |
| OPTN | Autophagy receptor with ubiquitin-binding domains | Implicated in mitophagy and neurodegeneration |
| NBR1 | Autophagy receptor | Recognizes ubiquitinated substrates |
| TAX1BP1 | Autophagy receptor | Facilitates selective autophagy |
| CALCOCO2 (NDP52) | Autophagy receptor | Binds ubiquitin chains on bacteria and mitochondria |
| UBA1 | E1 ubiquitin-activating enzyme | Initiates ubiquitin transfer cascade |
| UBE2D1 | E2 ubiquitin-conjugating enzyme | Works with E3 ligases |
| UBE2L3 | E2 ubiquitin-conjugating enzyme | Associated with inflammatory diseases |
| VPS34 | PI3K involved in autophagy initiation | Crosstalk with ubiquitin pathways |
How Is ubiquitin-protein transferase activity Regulated?
Ubiquitin-protein transferase activity is regulated at multiple levels. PINK1 phosphorylates ubiquitin and Parkin to activate Parkin E3 ligase activity, a key switch in mitophagy. Molecular glues can allosterically activate Parkin, showing pharmacological regulation. The AMPK/ULK1 axis couples energy status to mitophagy, influencing ubiquitin-dependent clearance. RAB7 activity is required for mitophagy in oocyte meiosis, linking GTPase cycling to ubiquitin transfer. Additionally, oxidative stress and autophagy crosstalk modulate the pathway.
ubiquitin-protein transferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKN | Parkinson's disease | Knockout or point-mutation iPSC-derived neurons |
| PINK1 | Parkinson's disease | Knockout mouse models and patient fibroblasts |
| RAB7 | Ovarian aging | Oocyte-specific knockout mouse |
| NLRP3 | Inflammatory disorders | Knockout macrophages and inflammasome assays |
| STING1 | Autoinflammatory interferonopathies | Knockout cells and STING reporter assays |
Parkinson's Disease and Neurodegeneration
Mutations in PINK1 and PRKN cause early-onset Parkinson's disease. PINK1 phosphorylates ubiquitin to activate Parkin E3 ligase activity, and loss of this pathway leads to mitochondrial dysfunction and dopaminergic neuron death. Parkin activation by molecular glues is being explored as a therapeutic strategy.
Inflammation and Innate Immunity
PINK1/Parkin-mediated mitophagy suppresses STING-induced inflammation by clearing damaged mitochondria that release mtDNA. Viral proteins can trigger centromeric DNA amplification that activates nuclear cGAS, linking ubiquitin pathways to immune sensing. NLRP3 inflammasome activation is maintained by ALDOA via AMPK, connecting metabolism to inflammation.
Ovarian Aging and Reproductive Health
RAB7 activity is required for mitophagy regulation in oocyte meiosis and oocyte quality control during ovarian aging, highlighting the role of ubiquitin-dependent processes in reproductive aging.
Oxidative Stress and Autophagy
Mitochondrial-endoplasmic reticulum communication mediates oxidative stress and autophagy, processes that intersect with ubiquitin transfer. Dysregulation can lead to accumulation of damaged proteins and organelles.
From ubiquitin-protein transferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRKN impair mitophagy? | PRKN knockout cell line (HeLa, SH-SY5Y) |
| Does a point mutation in PINK1 abolish ubiquitin phosphorylation? | PINK1 point-mutation knock-in via CRISPR |
| Can a molecular glue activate Parkin? | Parkin knock-in with tagged ubiquitin reporter |
| How does RAB7 affect oocyte quality? | RAB7 conditional knockout mouse |
| Does NLRP3 require ALDOA for activation? | ALDOA knockout macrophages |
| Does STING drive inflammation in Parkin deficiency? | Parkin/STING double knockout mouse |
How to Study the ubiquitin-protein transferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ubiquitination assay | Ubiquitin transfer to substrate | Enzyme kinetics and substrate specificity |
| Western blot for ubiquitin | Total ubiquitin conjugates | Pathway activation in cells |
| mt-Keima imaging | Mitophagy flux | Live-cell mitophagy |
| DiGly proteomics | Ubiquitinated peptides | Global ubiquitin landscape |
| CRISPR knockout screen | Gene requirement for pathway | Identify regulators of mitophagy |
| Immunoprecipitation | Protein interactions | E3-substrate validation |
| Phospho-ubiquitin blot | PINK1 activity | Parkin activation status |
| Molecular glue assay | Parkin activation | Drug discovery |
Ubiquitination Assays
In vitro ubiquitination assays using recombinant E1, E2, E3, and ubiquitin measure the transfer of ubiquitin to substrates. These assays can be coupled with Western blotting for ubiquitin conjugates or mass spectrometry to identify modified lysines.
Mitophagy Flux Analysis
Mitophagy is measured using fluorescent reporters (e.g., mt-Keima) or by tracking mitochondrial protein degradation in the presence of lysosomal inhibitors. This assesses the functional consequence of ubiquitin transfer on mitochondria.
Proteomics and Ubiquitin Remnant Profiling
Mass spectrometry-based proteomics can identify ubiquitinated proteins and sites. DiGly remnant profiling enriches ubiquitinated peptides to map the ubiquitin landscape after genetic perturbation.
CRISPR Screens for Modifiers
Genome-wide CRISPR knockout or activation screens can identify genes that regulate ubiquitin transfer or mitophagy. These screens link candidate genes to the pathway and reveal new therapeutic targets.
How CRISPR Can Be Used to Study GO:0004842 ubiquitin-protein transferase activity
Knockout
CRISPR knockout of PRKN or PINK1 abolishes ubiquitin transfer to mitochondrial substrates, leading to impaired mitophagy and accumulation of damaged mitochondria. These models are used to study Parkinson's disease mechanisms and to test rescue strategies.
Point Mutation
Point mutations in the catalytic cysteine of Parkin or in the kinase domain of PINK1 can be introduced to dissect enzymatic activity. Such models help distinguish loss-of-function from gain-of-function effects.
Knock-in
Knock-in of tagged ubiquitin or Parkin allows real-time tracking of ubiquitin transfer. Tagged knock-in models are valuable for imaging and proteomic studies.
Overexpression
Overexpression of Parkin or PINK1 can enhance ubiquitin transfer and mitophagy, providing a gain-of-function system to study pathway activation and drug responses.
How EDITGENE Supports ubiquitin-protein transferase activity Research
Researchers studying ubiquitin-protein transferase activity-related genes often need to determine whether a candidate gene is causally involved in the pathway or is merely a bystander. EDITGENE provides CRISPR-based cell models and screening services to interrogate gene function with precision.
Contact EDITGENE today to design your custom CRISPR model for ubiquitin-protein transferase activity research.
Frequently Asked Questions About ubiquitin-protein transferase activity
What is ubiquitin-protein transferase activity?
It is the catalytic transfer of ubiquitin from a donor to an acceptor protein, forming a covalent linkage, as defined by GO:0004842.
What genes are involved in ubiquitin-protein transferase activity?
Key genes include PINK1, PRKN (Parkin), UBA1, UBE2D1, and autophagy receptors such as SQSTM1.
How is ubiquitin-protein transferase activity regulated?
It is regulated by phosphorylation (e.g., PINK1), energy sensors (AMPK/ULK1), and small molecules like molecular glues.
What diseases are linked to ubiquitin-protein transferase activity?
Parkinson's disease, inflammatory disorders, and ovarian aging are linked to dysfunction in this pathway.
What is the role of Parkin in ubiquitin transfer?
Parkin is an E3 ligase that transfers ubiquitin to mitochondrial substrates, and its activation requires PINK1.
How can I study ubiquitin-protein transferase activity in the lab?
Use in vitro ubiquitination assays, mitophagy reporters, proteomics, and CRISPR screens.
What is the PINK1/Parkin pathway?
It is a mitochondrial quality control pathway where PINK1 phosphorylates ubiquitin to activate Parkin, leading to mitophagy.
Can ubiquitin-protein transferase activity be targeted therapeutically?
Yes, molecular glues that activate Parkin are being developed for neurodegeneration.
What is the difference between E2 and E3 enzymes?
E2 conjugating enzymes carry ubiquitin, while E3 ligases provide substrate specificity.
How does mitophagy relate to ubiquitin transfer?
Mitophagy requires ubiquitin tagging of mitochondrial proteins to recruit autophagy receptors.
Conclusion
GO:0004842 ubiquitin-protein transferase activity is a fundamental molecular function that orchestrates protein fate and organelle quality control. Its dysregulation underlies major human diseases, particularly neurodegeneration and inflammation. Continued research using CRISPR models and advanced proteomics will illuminate new therapeutic opportunities.
References
- 1. Kane LA et al.. 2014. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.. J Cell Biol 205(2):143-53 PMID: 24751536
- 2. Liu X et al.. 2022. Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy.. Biomed Res Int 2022:6459585 PMID: 36164446
- 3. Bai D et al.. 2022. ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation.. Autophagy 18(7):1673-1693 PMID: 34821530
- 4. Sliter DA et al.. 2018. Parkin and PINK1 mitigate STING-induced inflammation.. Nature 561(7722):258-262 PMID: 30135585
- 5. Lahaye X et al.. 2025. Centromeric DNA amplification triggered by viral proteins activates nuclear cGAS.. Cell 188(15):4043-4057.e21 PMID: 40460826
- 6. Iorio R et al.. 2021. Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK/ULK1 Axis.. Cells 11(1) PMID: 35011593
- 7. Jin X et al.. 2022. RAB7 activity is required for the regulation of mitophagy in oocyte meiosis and oocyte quality control during ovarian aging.. Autophagy 18(3):643-660 PMID: 34229552
- 8. Sauvé V et al.. 2024. Activation of parkin by a molecular glue.. Nat Commun 15(1):7707 PMID: 39300082
